Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
15.53
+0.07 (0.45%)
At close: Oct 9, 2026, 4:00 PM EDT
15.52
-0.01 (-0.06%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $999.43 million as of October 9, 2026. It is the 10,308th most valuable company in the world and the 2,245th biggest in the United States. Its market cap has increased by 162.30% in one year.
Market Cap
999.43M
Enterprise Value
666.96M
1-Year Change
162.30%
Global Rank
Country Rank
#2,245 United States
Category
ChartMarket Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has increased from $829.45M to $999.43M, an increase of 20.49%. That is a compound annual growth rate of 3.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 999.43M | 63.46% |
| Dec 31, 2025 | 611.44M | -13.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LB Pharmaceuticals | 1.11B |
| Bicara Therapeutics | 1.09B |
| Vor Biopharma | 1.08B |
| Latigo Biotherapeutics | 1.07B |
| Janux Therapeutics | 1.02B |
| MeiraGTx Holdings | 1.02B |
| Immatics | 1.02B |
| Aktis Oncology | 991.70M |